570 related articles for article (PubMed ID: 8548938)
1. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
Newell-Price J; Trainer P; Perry L; Wass J; Grossman A; Besser M
Clin Endocrinol (Oxf); 1995 Nov; 43(5):545-50. PubMed ID: 8548938
[TBL] [Abstract][Full Text] [Related]
2. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
Görges R; Knappe G; Gerl H; Ventz M; Stahl F
J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
[TBL] [Abstract][Full Text] [Related]
4. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW
Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
6. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings.
Blunt SB; Sandler LM; Burrin JM; Joplin GF
Q J Med; 1990 Nov; 77(283):1113-33. PubMed ID: 2177207
[TBL] [Abstract][Full Text] [Related]
8. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
9. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
Montwill J; Igoe D; McKenna TJ
Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic efficacy of midnight cortisol and midnight ACTH in the diagnosis and localisation of Cushing's syndrome.
John M; Lila AR; Bandgar T; Menon PS; Shah NS
Pituitary; 2010; 13(1):48-53. PubMed ID: 19714471
[TBL] [Abstract][Full Text] [Related]
12. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome.
Martin NM; Dhillo WS; Banerjee A; Abdulali A; Jayasena CN; Donaldson M; Todd JF; Meeran K
J Clin Endocrinol Metab; 2006 Jul; 91(7):2582-6. PubMed ID: 16670165
[TBL] [Abstract][Full Text] [Related]
14. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.
Yaneva M; Mosnier-Pudar H; Dugué MA; Grabar S; Fulla Y; Bertagna X
J Clin Endocrinol Metab; 2004 Jul; 89(7):3345-51. PubMed ID: 15240613
[TBL] [Abstract][Full Text] [Related]
15. Late-night salivary cortisol as a screening test for Cushing's syndrome.
Raff H; Raff JL; Findling JW
J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
17. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
Barrou Z; Guiban D; Maroufi A; Fournier C; Dugué MA; Luton JP; Thomopoulos P
Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.
Meikle AW
Clin Endocrinol (Oxf); 1982 Apr; 16(4):401-8. PubMed ID: 7094363
[TBL] [Abstract][Full Text] [Related]
19. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
Tang TJ; Liu YP; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
[TBL] [Abstract][Full Text] [Related]
20. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
